v3.25.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 4,316 $ 4,965
Accounts receivable, net 113 186
Prepaid expenses and other current assets 321 118
Total current assets 4,750 5,269
Other assets 5 6
Total assets 4,755 5,275
Current liabilities:    
Accounts payable 70 105
Accrued expenses and other current liabilities 1,294 1,131
Deferred revenue 41 36
Total current liabilities 1,405 1,272
Total liabilities 1,405 1,272
Commitments and contingencies (see Note 8)
Stockholders’ equity:    
Preferred stock Series F, convertible; $0.0001 par value; $586,450 stated value; 5,000,000 shares authorized, 545 shares issued and outstanding as of March 31, 2025, and December 31, 2024 0 0
Common stock; $0.0001 par value; 150,000,000 shares authorized, 1,154,926 and 1,154,737 shares issued and outstanding as of March 31, 2025, respectively, and 1,144,926 and 1,144,737 shares issued and outstanding as of December 31, 2024, respectively 0 0
Treasury Stock, 189 common shares (181) (181)
Additional paid-in capital 236,477 236,458
Accumulated deficit (232,946) (232,274)
Total stockholders’ equity 3,350 4,003
Total liabilities and stockholders’ equity $ 4,755 $ 5,275